SetPoint nerve stimulator for RRMS accepted to FDA TAP program
Pilot program to help accelerate patient access to innovative devices by Andrea Lobo, PhD | March 26, 2024 The U.S. Food and Drug…
Muscle Relaxants for MS Spasticity: 6 Tips for Safe Use
Medically reviewed by Jazmin N. McSwain, PharmD, BCPS / Written by Remi A. Kessler, M.D. Posted on May 22, 2023 Did you…
Stuart Schlossman
Why Are MS Muscle Spasms Worse at Night?
Medically reviewed by Joseph V. Campellone, M.D. Updated on February 1, 2024 (though you cannot see it, I think my name…
Stuart Schlossman
EU agency OKs study of therapy to improve mitochondrial function
Trial of MP101 to enroll patients with MS, other neurodegenerative diseases by Andrea Lobo, PhD | January 16, 2024 Mitochon Pharmaceuticals is launching a…
Stuart Schlossman
What Is a Wash-Out Period? 8 Things To Know for DMTs (Disease Modifying Therapies)
Written by Maureen McNulty Medically reviewed by Luc Jasmin, M.D., Ph.D., FRCS (C), FACS If you have multiple sclerosis (MS) and want…
Stuart Schlossman
Signs That You’re Transitioning to Another Stage of MS
Signs That You’re Transitioning to Another Stage of MS Research show that Blacks develop Multiple Sclerosis more often…
Stuart Schlossman
Reframing MS — A new Patient resource with Jamie-Lynn Sigler (Sopranos)
Novartis is collaborating with mom, actor, MS advocate, and KESIMPTA patient Jamie-Lynn Sigler to share what she has learned in…
Stuart Schlossman
Barriers in MS Treatment Adherence
2023 , Octave Although there currently is no cure for multiple sclerosis, in recent decades, 20+ disease-modifying therapies (DMTs)…
Stuart Schlossman
Affordable, accessible apartments designed just for people with MS make life easier for them.
Affordable, accessible apartments designed just for people with MS make life easier for them. by Matt Alderton The year…
Stuart Schlossman
Genetic risk found similar between RRMS, PPMS in Swedish study
Familial risk for both subtypes was highest among full siblings by Lindsey Shapiro, PhD | July 25, 2023 The risk of developing multiple…
Stuart Schlossman
